Results 51 to 60 of about 54,991 (287)

Prodrugs of New Psychoactive Substances (NPS): A New Challenge [PDF]

open access: yesJournal of Forensic Sciences, 2020
AbstractThe concept of a substance acting as a prodrug for an intended drug is not new and has been known and utilized with particular benefits within medicine for efficacy and patient safety. Prodrugs of psychoactive substances are also not particularly new but this has also extended to considerations of prodrugs of new psychoactive substances (NPS ...
Elliott, S, Holdbrook, T, Brandt, SD
openaire   +2 more sources

New psychoactive substances abuse and its clinical consequences - the case report

open access: yesJournal of Education, Health and Sport, 2019
Introduction: The meteoric rise of new psychoactive substances' use has been a public health problem for at least few years. Their presence was noticed by EU authorities around 2005.
Andrzej Kościuk   +5 more
doaj   +3 more sources

Report on characterisation of New Psychoactive Substances (NPS) [PDF]

open access: yes, 2015
The emergence of designer drugs as abused substances has seen a dramatic increase over the past few years. About 70 new psychoactive substances were discovered in 2012 and more than 80 in 2013. Customs and forensic laboratories are faced with a challenge
CHASSAIGNE HUBERT   +6 more
core   +1 more source

Contemporary management of pain in cirrhosis: Toward precision therapy for pain

open access: yesHepatology, EarlyView., 2022
Abstract Chronic pain is highly prevalent in patients with cirrhosis and is associated with poor health‐related quality of life and poor functional status. However, there is limited guidance on appropriate pain management in this population, and pharmacologic treatment can be harmful, leading to adverse outcomes, such as gastrointestinal bleeding ...
Alexis Holman   +4 more
wiley   +1 more source

Generic bans of new psychoactive substances [PDF]

open access: yesZbornik Radova: Pravni Fakultet u Novom Sadu, 2018
New psychoactive substances attract attention of the researchers for more than ten years. Their appearance and increasing presence in the drug market require an adequate response from all responsible state authorities.
Risimović Radosav S.
doaj  

The law on psychoactive substances in New Zealand: The end of the regulatory game of cat and mouse

open access: yes, 2013
This paper considers the recent global concern of psychoactive substance use alongside New Zealand’s corresponding endeavour to regulate such substances under the Psychoactive Substances Act 2013.
Holland, Kathryn
core   +2 more sources

Identification of the New Psychoactive Substance Eutylone.

open access: yesFa yi xue za zhi, 2022
To establish a method to identify unknown sample based on the combined use of Fourier transform infrared spectroscopy (FTIR), gas chromatography-quadrupole time-of-flight mass spectrometry (GC-QTOF-MS), ultra-high performance liquid chromatography-linear ion trap quadrupole-orbitrap mass spectrometry (UPLC-LTQ-Orbitrap MS) and 1H-nuclear magnetic ...
DENG Qian-ya   +6 more
openaire   +2 more sources

Recent Changes in Drug Abuse Scenario: The Novel Psychoactive Substances (NPS) Phenomenon [PDF]

open access: yes, 2019
copyright 2019 by the authors. Articles in this book are Open Access and distributed under the Creative Commons Attribution (CC BY) license, which allows users to download, copy and build upon published articles, as long as the author and publisher are ...
Catalani, Valeria   +7 more
core   +3 more sources

Sex‐Stratified Association of Regional Dopamine Transporter Binding With Disease Progression in Amyotrophic Lateral Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To clarify the clinical relevance of dopamine transporter single‐photon emission computed tomography (DAT‐SPECT) abnormalities in amyotrophic lateral sclerosis (ALS), with a prespecified focus on sex‐stratified associations with disease progression and short‐term prognosis.
Tomoya Kawazoe   +7 more
wiley   +1 more source

Closing Evidence Gaps on the Prevalence and Harms of New Psychoactive Substances in Scotland [PDF]

open access: yes, 2015
This paper considers the state of knowledge on New Psychoactive Substances (NPS) in Scotland, with a focus on prevalence and harms and puts forward proposals which may assist in closing existing evidence ...
Gillies, Allan
core  

Home - About - Disclaimer - Privacy